LIU X Q， JIANG L， LEI L， et al. Carnosine alleviates diabetic nephropathy by targeting GNMT， a key enzyme mediating renal inflammation and fibrosis［J］. Clin Sci， 2020， 134（23）： 3175-3193.

XU L， LIN X， GUAN M， et al. Verapamil attenuated prediabetic neuropathy in high-fat diet-fed mice through inhibiting TXNIP-mediated apoptosis and inflammation［J］. Oxid Med Cell Longev， 2019（2019）： 1896041.

XU L L， GAO W， CHEN Z M， et al. Relationships between diabetic nephropathy and insulin resistance， inflammation， Trx， Txnip， CysC and serum complement levels［J］. Eur Rev Med Pharmacol Sci， 2020， 24（22）： 11700-11706.

ZHU L L， WANG H Y， TANG T. Effects of miR-195 on diabetic nephropathy rats through targeting TLR4 and blocking NF-κB pathway［J］. Eur Rev Med Pharmacol Sci， 2021， 25（3）： 1522-1529.

MITCHELL J P， CARMODY R J. NF-κB and the transcriptional control of inflammation［J］. Int Rev Cell Mol Biol， 2018（335）： 41-84.

WANG S G， YANG Z Y， XIONG F X， et al. Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-kappa B signaling pathway［J］. Mol Cell Endocrinol， 2016（434）： 135-143.

HAYDEN M S， GHOSH S. NF-κB， the first quarter-century： remarkable progress and outstanding questions［J］. Genes Dev， 2012， 26（3）： 203-234.

SHAO Y X， GONG Q， QI X M， et al. Paeoniflorin ameliorates macrophage infiltration and activation by inhibiting the TLR4 signaling pathway in diabetic nephropathy［J］. Front Pharmacol， 2019， 22（10）： 566.

SHIMIZU M， FURUICHI K， WADA T. Epidemiology and pathogenesis of diabetic nephropathy［J］. Nihon Jinzo Gakkaishi， 2017， 59（2）： 43-49.

YANG H， XIE T， LI D， et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway［J］. Mol Metab， 2019（23）： 24-36．

ZHANG Y Y， TAN R Z， ZHANG X Q， et al. Calycosin ameliorates diabetes-induced renal inflammation via the NF-κBpathway in vitro and in vivo［J］. Med Sci Monit， 2019（25）： 1671-1678.

CHEN J， YANG Y， LV Z， et al. Study on the inhibitive effect of Catalpol on diabetic nephropathy［J］. Life Sciences， 2020（257） ： 118120.

DONG W H， CHU Q Q， LIU S Q， et al. Isobavachalcone ameliorates diabetic nephropathy in rats by inhibiting the NF-κB pathway［J］. J Food Biochem， 2020，44（9）： e13405.

LUO R. Qi-dan-di-huang decoction alleviates diabetic nephropathy by inhibiting the NF-kappaB pathway［J］. Front Biosci， 2019， 24（8）： 1477-1486.

TIM V ， KARINA S， HOLGER H，et al. RNA is taking its Toll ： Impact of RNA-specific Toll-like receptors on health and disease［J］. Allergy， 2019，74（2）： 223-235.

GARIBOTTO G， CARTA A， PICCIOTTO D， et al. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy［J］. J Nephrol， 2017， 30（6）： 719-727.

ZHU L， HAN J， YUAN R， et al. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway［J］.Biol Res， 2018， 51（1）： 173-182.

WANG H Q ， WANGS S ， KUOK C F， et al. Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR/NF-κB pathway［J］. Chin J Nat Med， 2019， 17（5）： 346-354.

白宇，杨丽霞，贺云，等. 当归多糖通过TLR4/NF-κB信号通路对糖尿病肾病大鼠的影响［J］. 中成药，2021，43（3）：755-760.

ZHANG S F， LI X， LIANG R F， et al. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells［J］. J Physiol Biochem， 2020， 76（3）： 407-416.

CAI S，HEN J C， LI Y.Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF-κB pathway in mice［J］. Immunobiology， 2020， 225（3）： 151941.

李志俊. 黄芪汤通过抑制TLR4/NF-κB信号通路改善糖尿病肾病大鼠的炎症反应［D］.上海：上海中医药大学，2019.

SONG W， WEI L， DU Y， et al. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice［J］. Int Immunopha-rmacol， 2018（63）： 227-238.

YU G， YU H， YANG Q， et al. Vibrio harveyi infections induce production of proinflammatory cytokines in murine peritoneal macrophages via activation of p38 MAPK and NF-κB pathways， but reversed by PI3K/AKT pathways［J］. Dev Comp Immunol， 2021（127）： 104292.

HAN J， PANG X， ZHANG Y， et al. Hirudin protects against kidney damage in streptozotocin-induced diabetic nephropathy rats by inhibiting inflammation via P38 MAPK/NF-κB pathway［J］. Drug Des Devel Ther， 2020（14）： 3223-3234.

ZHANG M， CHEN Y， YANG M J， et al. Celastrol attenuates renal injury in diabetic rats via MAPK/NF-κB pathway［J］. Phytother Res， 2019， 33（4）： 1191-1198.

CHEN M F， LIOU S S， KAO S T， et al. Erianin protects against high glucose-induced oxidative injury in renal tubular epithelial cells［J］. Food Chem Toxicol， 2019（126）： 97-105.

ISHA S， TUPE R S， WALLNER A K， et al. Contribution of myo-inositol oxygenase in AGE： RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy［J］. Am J Physiol Renal Physiol， 2018， 314（1）： 107-121.

GAO L， ZIMMERMAN M C， BISWAL S， et al. Selective Nrf2 gene deletion in the rostral ventrolateral medulla evokes hypertension and sympathoexcitation in mice［J］. Hypertension， 2017， 69（6）： 1198-1206.

JING C R， REGAN R F. Targeting the Nrf2-heme oxygenase-1 axis after intracerebralhemorrhage［J］. Curr Pharm Des， 2017， 23（15）： 2226-2237.

BAO L， LI J， ZHA D， et al. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-B pathways［J］. Int Immunopha-rmacol， 2017（54）： 245-253.

LU C， FAN G， WANG D. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway［J］. Int Immunopharmacol， 2020（84）： 106467.

ALAOFI A L. Sinapic acid ameliorates the progression of streptozotocin（STZ）-induced diabetic nephropathy in rats via NRF2/HO-1 mediated pathways［J］. Front Pharmacol， 2020（11）： 1119.

LI H， WANG D， CHEN Y， et al. β-Caryophyllene inhibits high glucose-induced oxidative stress， inflammation and extracellular matrix accumulation in mesangialcells［J］. Int Immunopharmacol， 2020（84）： 106556.

WU Z， CHEN J， ZHAO W， et al. Inhibition of miR-181a attenuates sepsis-induced inflammation and apoptosis by activating Nrf2 and inhibiting NF-κB pathways via targeting SIRT1［J］. Kaohsiung J Med Sci， 2021， 37（3）： 200-207.

GAO J， CHEN Q Q， HUANG Y， et al. Design， synthesis and pharmacological evaluation of naphthofuran derivatives as potent SIRT1 activators［J］. Front Pharmacol， 2021（12）： 653233.

WANG X， GAO Y， TIAN N， et al. Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis［J］. Sci Rep， 2019， 9（1）： 323.

LI F， CHEN Y， LI Y， et al. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway［J］.Eur J Pharmacol， 2020（886）： 173449.

LIU Y， LIU W， ZHANG Z， et al. Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy［J］. Ren Fail， 2021，43（1）： 128-140.